APO Research
Talk to an analyst

APO RESEARCH · REPORT

Single Cell Genomics and Proteomics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Single Cell Genomics and Proteomics Market Outlook and Growth Opportunities 2026

11 April 2026Not stated

Choose your research edition.

Industry ResearchSingle Cell Genomics and Proteomics Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Single Cell Genomics and Proteomics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Single Cell Genomics and Proteomics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single Cell Genomics and Proteomics Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Single Cell Genomics and Proteomics Market Analysis and Forecast 2026-2032258 pages · $4,950 USD

Market perspective

The global Single Cell Genomics and Proteomics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Single Cell Genomics and Proteomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Single Cell Genomics and Proteomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Single Cell Genomics and Proteomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Single Cell Genomics and Proteomics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Single Cell Genomics and Proteomics market include 10x Genomics, Inc., Standard BioTools Inc, QIAGEN GmbH, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Exact Sciences Corporation, Accelerate Diagnostics, Inc., Bio-Rad Laboratories, Inc. and Epic Sciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Single Cell Genomics and Proteomics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Single Cell Genomics and Proteomics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Single Cell Genomics and Proteomics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Single Cell Genomics and Proteomics market.

Single Cell Genomics and Proteomics Segment by Company

10x Genomics, Inc.

Standard BioTools Inc

QIAGEN GmbH

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

Exact Sciences Corporation

Accelerate Diagnostics, Inc.

Bio-Rad Laboratories, Inc.

Epic Sciences, Inc.

Yikon Genomics Co., Ltd.

Takara Bio Inc.

1CellBio, Inc.

Bio-Techne Corporation

Single Cell Genomics and Proteomics Segment by Type

Cell Isolation

Sample Preparation

Genomic Analysis

Single Cell Genomics and Proteomics Segment by Application

Genomic Variation

Subpopulation Characterization

Circulating Tumor Cells

Cell Differentiation

Others

Single Cell Genomics and Proteomics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Single Cell Genomics and Proteomics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Single Cell Genomics and Proteomics key companies, revenue, market share, and recent developments.

3. To split the Single Cell Genomics and Proteomics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Single Cell Genomics and Proteomics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Single Cell Genomics and Proteomics significant trends, drivers, influence factors in global and regions.

6. To analyze Single Cell Genomics and Proteomics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Cell Genomics and Proteomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single Cell Genomics and Proteomics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Cell Genomics and Proteomics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Single Cell Genomics and Proteomics industry.

Chapter 3: Detailed analysis of Single Cell Genomics and Proteomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Single Cell Genomics and Proteomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Single Cell Genomics and Proteomics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Single Cell Genomics and Proteomics Industry Trends Table 2. Single Cell Genomics and Proteomics Industry Drivers Table 3. Single Cell Genomics and Proteomics Industry Opportunities and Challenges Table 4. Single Cell Genomics and Proteomics Industry Restraints Table 5. Global Single Cell Genomics and Proteomics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Single Cell Genomics and Proteomics Revenue Share by Company (2021-2026) Table 7. Global Single Cell Genomics and Proteomics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Single Cell Genomics and Proteomics Key Company Manufacturing Base & Headquarters Table 9. Global Single Cell Genomics and Proteomics Company, Product Type & Application Table 10. Global Single Cell Genomics and Proteomics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Single Cell Genomics and Proteomics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cell Isolation Table 15. Significant Companies of Sample Preparation Table 16. Significant Companies of Genomic Analysis Table 17. Global Single Cell Genomics and Proteomics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Single Cell Genomics and Proteomics Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Single Cell Genomics and Proteomics Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Single Cell Genomics and Proteomics Sales Value Share by Type (2021-2026) Table 21. Global Single Cell Genomics and Proteomics Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Genomic Variation Table 23. Significant Companies of Subpopulation Characterization Table 24. Significant Companies of Circulating Tumor Cells Table 25. Significant Companies of Cell Differentiation Table 26. Significant Companies of Others Table 27. Global Single Cell Genomics and Proteomics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Single Cell Genomics and Proteomics Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Single Cell Genomics and Proteomics Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Single Cell Genomics and Proteomics Sales Value Share by Application (2021-2026) Table 31. Global Single Cell Genomics and Proteomics Sales Value Share by Application (2027-2032) Table 32. Global Single Cell Genomics and Proteomics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Single Cell Genomics and Proteomics Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Single Cell Genomics and Proteomics Sales Value Share by Region (2021-2026) Table 35. Global Single Cell Genomics and Proteomics Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Single Cell Genomics and Proteomics Sales Value Share by Region (2027-2032) Table 37. Global Single Cell Genomics and Proteomics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Single Cell Genomics and Proteomics Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Single Cell Genomics and Proteomics Sales Value Market Share by Country (2021-2026) Table 40. Global Single Cell Genomics and Proteomics Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Single Cell Genomics and Proteomics Sales Value Market Share by Country (2027-2032) Table 42. 10x Genomics, Inc. Company Information Table 43. 10x Genomics, Inc. Business Overview Table 44. 10x Genomics, Inc. Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. 10x Genomics, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 46. 10x Genomics, Inc. Recent Development Table 47. Standard BioTools Inc Company Information Table 48. Standard BioTools Inc Business Overview Table 49. Standard BioTools Inc Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Standard BioTools Inc Single Cell Genomics and Proteomics Product Portfolio Table 51. Standard BioTools Inc Recent Development Table 52. QIAGEN GmbH Company Information Table 53. QIAGEN GmbH Business Overview Table 54. QIAGEN GmbH Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. QIAGEN GmbH Single Cell Genomics and Proteomics Product Portfolio Table 56. QIAGEN GmbH Recent Development Table 57. Thermo Fisher Scientific Inc. Company Information Table 58. Thermo Fisher Scientific Inc. Business Overview Table 59. Thermo Fisher Scientific Inc. Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Thermo Fisher Scientific Inc. Single Cell Genomics and Proteomics Product Portfolio Table 61. Thermo Fisher Scientific Inc. Recent Development Table 62. Agilent Technologies, Inc. Company Information Table 63. Agilent Technologies, Inc. Business Overview Table 64. Agilent Technologies, Inc. Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Agilent Technologies, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 66. Agilent Technologies, Inc. Recent Development Table 67. Exact Sciences Corporation Company Information Table 68. Exact Sciences Corporation Business Overview Table 69. Exact Sciences Corporation Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Exact Sciences Corporation Single Cell Genomics and Proteomics Product Portfolio Table 71. Exact Sciences Corporation Recent Development Table 72. Accelerate Diagnostics, Inc. Company Information Table 73. Accelerate Diagnostics, Inc. Business Overview Table 74. Accelerate Diagnostics, Inc. Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Accelerate Diagnostics, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 76. Accelerate Diagnostics, Inc. Recent Development Table 77. Bio-Rad Laboratories, Inc. Company Information Table 78. Bio-Rad Laboratories, Inc. Business Overview Table 79. Bio-Rad Laboratories, Inc. Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Bio-Rad Laboratories, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 81. Bio-Rad Laboratories, Inc. Recent Development Table 82. Epic Sciences, Inc. Company Information Table 83. Epic Sciences, Inc. Business Overview Table 84. Epic Sciences, Inc. Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Epic Sciences, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 86. Epic Sciences, Inc. Recent Development Table 87. Yikon Genomics Co., Ltd. Company Information Table 88. Yikon Genomics Co., Ltd. Business Overview Table 89. Yikon Genomics Co., Ltd. Single Cell Genomics and Proteomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Yikon Genomics Co., Ltd. Single Cell Genomics and Proteomics Product Portfolio Table 91. Yikon Genomics Co., Ltd. Recent Development Table 92. Takara Bio Inc. Company Information Table 93. Takara Bio Inc. Business Overview Table 94. Takara Bio Inc. Single Cell Genomics and Proteomics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Takara Bio Inc. Single Cell Genomics and Proteomics Product Portfolio Table 96. Takara Bio Inc. Recent Development Table 97. 1CellBio, Inc. Company Information Table 98. 1CellBio, Inc. Business Overview Table 99. 1CellBio, Inc. Single Cell Genomics and Proteomics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. 1CellBio, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 101. 1CellBio, Inc. Recent Development Table 102. Bio-Techne Corporation Company Information Table 103. Bio-Techne Corporation Business Overview Table 104. Bio-Techne Corporation Single Cell Genomics and Proteomics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Bio-Techne Corporation Single Cell Genomics and Proteomics Product Portfolio Table 106. Bio-Techne Corporation Recent Development Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Single Cell Genomics and Proteomics Product Image Figure 2. Global Single Cell Genomics and Proteomics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Single Cell Genomics and Proteomics Market Size (2021-2032) & (US$ Million) Figure 4. Global Single Cell Genomics and Proteomics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cell Isolation Image Figure 8. Sample Preparation Image Figure 9. Genomic Analysis Image Figure 10. Global Single Cell Genomics and Proteomics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Single Cell Genomics and Proteomics Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Single Cell Genomics and Proteomics Sales Value Share by Type (2021-2032) Figure 13. Genomic Variation Image Figure 14. Subpopulation Characterization Image Figure 15. Circulating Tumor Cells Image Figure 16. Cell Differentiation Image Figure 17. Others Image Figure 18. Global Single Cell Genomics and Proteomics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Single Cell Genomics and Proteomics Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Single Cell Genomics and Proteomics Sales Value Share by Application (2021-2032) Figure 21. Global Single Cell Genomics and Proteomics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Single Cell Genomics and Proteomics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Single Cell Genomics and Proteomics Sales Value (2021-2032) & (US$ Million) Figure 24. North America Single Cell Genomics and Proteomics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Single Cell Genomics and Proteomics Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Single Cell Genomics and Proteomics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Single Cell Genomics and Proteomics Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Single Cell Genomics and Proteomics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Single Cell Genomics and Proteomics Sales Value (2021-2032) & (US$ Million) Figure 30. South America Single Cell Genomics and Proteomics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Single Cell Genomics and Proteomics Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Single Cell Genomics and Proteomics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Cell Isolation
  • Sample Preparation
  • Genomic Analysis
Applications
  • Genomic Variation
  • Subpopulation Characterization
  • Circulating Tumor Cells
  • Cell Differentiation
  • Others
Companies covered
  • 10x Genomics, Inc.
  • Standard BioTools Inc
  • QIAGEN GmbH
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Exact Sciences Corporation
  • Accelerate Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Epic Sciences, Inc.
  • Yikon Genomics Co., Ltd.
  • Takara Bio Inc.
  • 1CellBio, Inc.
  • Bio-Techne Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Single Cell Genomics and Proteomics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Single Cell Genomics and Proteomics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Single Cell Genomics and Proteomics Market Dynamics
  1. 2.1 Single Cell Genomics and Proteomics Industry Trends
  2. 2.2 Single Cell Genomics and Proteomics Industry Drivers
  3. 2.3 Single Cell Genomics and Proteomics Industry Opportunities and Challenges
  4. 2.4 Single Cell Genomics and Proteomics Industry Restraints
3 Single Cell Genomics and Proteomics Market by Company
  1. 3.1 Global Single Cell Genomics and Proteomics Company Revenue Ranking in 2025
  2. 3.2 Global Single Cell Genomics and Proteomics Revenue by Company (2021-2026)
  3. 3.3 Global Single Cell Genomics and Proteomics Company Ranking (2024-2026)
  4. 3.4 Global Single Cell Genomics and Proteomics Company Manufacturing Base and Headquarters
  5. 3.5 Global Single Cell Genomics and Proteomics Company Product Type and Application
  6. 3.6 Global Single Cell Genomics and Proteomics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Single Cell Genomics and Proteomics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Single Cell Genomics and Proteomics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Single Cell Genomics and Proteomics Market by Type
  1. 4.1 Single Cell Genomics and Proteomics Type Introduction
  2. 4.1.1 Cell Isolation
  3. 4.1.2 Sample Preparation
  4. 4.1.3 Genomic Analysis
  5. 4.2 Global Single Cell Genomics and Proteomics Sales Value by Type
  6. 4.2.1 Global Single Cell Genomics and Proteomics Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Single Cell Genomics and Proteomics Sales Value by Type (2021-2032)
  8. 4.2.3 Global Single Cell Genomics and Proteomics Sales Value Share by Type (2021-2032)
5 Single Cell Genomics and Proteomics Market by Application
  1. 5.1 Single Cell Genomics and Proteomics Application Introduction
  2. 5.1.1 Genomic Variation
  3. 5.1.2 Subpopulation Characterization
  4. 5.1.3 Circulating Tumor Cells
  5. 5.1.4 Cell Differentiation
  6. 5.1.5 Others
  7. 5.2 Global Single Cell Genomics and Proteomics Sales Value by Application
  8. 5.2.1 Global Single Cell Genomics and Proteomics Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Single Cell Genomics and Proteomics Sales Value by Application (2021-2032)
  10. 5.2.3 Global Single Cell Genomics and Proteomics Sales Value Share by Application (2021-2032)
6 Single Cell Genomics and Proteomics Regional Value Analysis
  1. 6.1 Global Single Cell Genomics and Proteomics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Single Cell Genomics and Proteomics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Single Cell Genomics and Proteomics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Single Cell Genomics and Proteomics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Single Cell Genomics and Proteomics Sales Value (2021-2032)
  7. 6.3.2 North America Single Cell Genomics and Proteomics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Single Cell Genomics and Proteomics Sales Value (2021-2032)
  10. 6.4.2 Europe Single Cell Genomics and Proteomics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Single Cell Genomics and Proteomics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Single Cell Genomics and Proteomics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Single Cell Genomics and Proteomics Sales Value (2021-2032)
  16. 6.6.2 South America Single Cell Genomics and Proteomics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Single Cell Genomics and Proteomics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Single Cell Genomics and Proteomics Sales Value Share by Country, 2025 VS 2032
7 Single Cell Genomics and Proteomics Country-level Value Analysis
  1. 7.1 Global Single Cell Genomics and Proteomics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Single Cell Genomics and Proteomics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Single Cell Genomics and Proteomics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Single Cell Genomics and Proteomics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Single Cell Genomics and Proteomics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Single Cell Genomics and Proteomics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Single Cell Genomics and Proteomics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 10x Genomics, Inc.
  2. 8.1.1 10x Genomics, Inc. Company Information
  3. 8.1.2 10x Genomics, Inc. Business Overview
  4. 8.1.3 10x Genomics, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 10x Genomics, Inc. Single Cell Genomics and Proteomics Product Portfolio
  6. 8.1.5 10x Genomics, Inc. Recent Developments
  7. 8.2 Standard BioTools Inc
  8. 8.2.1 Standard BioTools Inc Company Information
  9. 8.2.2 Standard BioTools Inc Business Overview
  10. 8.2.3 Standard BioTools Inc Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Standard BioTools Inc Single Cell Genomics and Proteomics Product Portfolio
  12. 8.2.5 Standard BioTools Inc Recent Developments
  13. 8.3 QIAGEN GmbH
  14. 8.3.1 QIAGEN GmbH Company Information
  15. 8.3.2 QIAGEN GmbH Business Overview
  16. 8.3.3 QIAGEN GmbH Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 QIAGEN GmbH Single Cell Genomics and Proteomics Product Portfolio
  18. 8.3.5 QIAGEN GmbH Recent Developments
  19. 8.4 Thermo Fisher Scientific Inc.
  20. 8.4.1 Thermo Fisher Scientific Inc. Company Information
  21. 8.4.2 Thermo Fisher Scientific Inc. Business Overview
  22. 8.4.3 Thermo Fisher Scientific Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Scientific Inc. Single Cell Genomics and Proteomics Product Portfolio
  24. 8.4.5 Thermo Fisher Scientific Inc. Recent Developments
  25. 8.5 Agilent Technologies, Inc.
  26. 8.5.1 Agilent Technologies, Inc. Company Information
  27. 8.5.2 Agilent Technologies, Inc. Business Overview
  28. 8.5.3 Agilent Technologies, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Agilent Technologies, Inc. Single Cell Genomics and Proteomics Product Portfolio
  30. 8.5.5 Agilent Technologies, Inc. Recent Developments
  31. 8.6 Exact Sciences Corporation
  32. 8.6.1 Exact Sciences Corporation Company Information
  33. 8.6.2 Exact Sciences Corporation Business Overview
  34. 8.6.3 Exact Sciences Corporation Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Exact Sciences Corporation Single Cell Genomics and Proteomics Product Portfolio
  36. 8.6.5 Exact Sciences Corporation Recent Developments
  37. 8.7 Accelerate Diagnostics, Inc.
  38. 8.7.1 Accelerate Diagnostics, Inc. Company Information
  39. 8.7.2 Accelerate Diagnostics, Inc. Business Overview
  40. 8.7.3 Accelerate Diagnostics, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Accelerate Diagnostics, Inc. Single Cell Genomics and Proteomics Product Portfolio
  42. 8.7.5 Accelerate Diagnostics, Inc. Recent Developments
  43. 8.8 Bio-Rad Laboratories, Inc.
  44. 8.8.1 Bio-Rad Laboratories, Inc. Company Information
  45. 8.8.2 Bio-Rad Laboratories, Inc. Business Overview
  46. 8.8.3 Bio-Rad Laboratories, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Rad Laboratories, Inc. Single Cell Genomics and Proteomics Product Portfolio
  48. 8.8.5 Bio-Rad Laboratories, Inc. Recent Developments
  49. 8.9 Epic Sciences, Inc.
  50. 8.9.1 Epic Sciences, Inc. Company Information
  51. 8.9.2 Epic Sciences, Inc. Business Overview
  52. 8.9.3 Epic Sciences, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Epic Sciences, Inc. Single Cell Genomics and Proteomics Product Portfolio
  54. 8.9.5 Epic Sciences, Inc. Recent Developments
  55. 8.10 Yikon Genomics Co., Ltd.
  56. 8.10.1 Yikon Genomics Co., Ltd. Company Information
  57. 8.10.2 Yikon Genomics Co., Ltd. Business Overview
  58. 8.10.3 Yikon Genomics Co., Ltd. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yikon Genomics Co., Ltd. Single Cell Genomics and Proteomics Product Portfolio
  60. 8.10.5 Yikon Genomics Co., Ltd. Recent Developments
  61. 8.11 Takara Bio Inc.
  62. 8.11.1 Takara Bio Inc. Company Information
  63. 8.11.2 Takara Bio Inc. Business Overview
  64. 8.11.3 Takara Bio Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Takara Bio Inc. Single Cell Genomics and Proteomics Product Portfolio
  66. 8.11.5 Takara Bio Inc. Recent Developments
  67. 8.12 1CellBio, Inc.
  68. 8.12.1 1CellBio, Inc. Company Information
  69. 8.12.2 1CellBio, Inc. Business Overview
  70. 8.12.3 1CellBio, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 1CellBio, Inc. Single Cell Genomics and Proteomics Product Portfolio
  72. 8.12.5 1CellBio, Inc. Recent Developments
  73. 8.13 Bio-Techne Corporation
  74. 8.13.1 Bio-Techne Corporation Company Information
  75. 8.13.2 Bio-Techne Corporation Business Overview
  76. 8.13.3 Bio-Techne Corporation Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bio-Techne Corporation Single Cell Genomics and Proteomics Product Portfolio
  78. 8.13.5 Bio-Techne Corporation Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst